Discover your potential savings with our ROI Calculator

Discover your potential savings with our ROI Calculator

mrb-closed-loop
Lipika Sharma
Lipika Sharma | December 10th, 2025

Unlock Consistent Quality and Audit Success by Moving MRB from Ad-hoc to Closed-Loop

Summary

Informal MRB practices in electronics, where rework and “use‑as‑is” decisions happen off the record, create repeat defects, audit exposure, and customer risk. ISO 9001 requires documented control of nonconforming outputs and the authority deciding dispositions (Clause 8.7), and it links those events to corrective action (Clause 10.2) to prevent recurrence. A structured, digital MRB ties every decision to the associated NCRs and CAPAs, keeps IPC‑A‑610 workmanship criteria central, and, when applicable, meets FDA 21 CFR 820.90 for nonconforming product control and documented justification. ComplianceQuest (CQ) operationalizes this: every MRB decision is logged, justified, and traceable to NCRs/CAPAs, with analytics to spot trends and reduce COPQ.

What Makes MRB Uniquely High‑stakes in Electronics?

Miniaturization and multi‑technology assemblies (SMT + through‑hole) elevate the risk of “hidden” workmanship escapes; IPC‑A‑610 codifies visual acceptance criteria and rework/repair boundaries that should drive MRB decisions. When MRB is informal, concessions drift away from those criteria and repeat failures surface later in functional test or the field.

Standards pressure adds urgency:

  • ISO 9001:2015 Clause 8.7 requires identification, segregation/quarantine, documented disposition (correction, return, concession) and retention of records including who authorized the decision; Clause 10.2 requires root‑cause and corrective action to prevent recurrence.
  • AS9100 (aerospace electronics) strengthens 8.7 control and expects documented MRB discipline and positive control of scrap or concessions.
  • IATF 16949 (auto electronics) tightens disposition rules; scrap must be rendered unusable and process controls prevent unintended use, MRB must be timely and traceable.
  • FDA 21 CFR 820.90 (medical electronics) mandates procedures for identification, segregation, evaluation and disposition, plus documented justification for any use of nonconforming product and signature authority.

“An MRB that doesn’t retain disposition records with approval authority is non‑compliant against ISO 9001:2015 8.7.2, and risks major audit findings.”

Why Ad‑hoc MRB Creates Systemic Risk (And Cost)

Symptoms of informal MRB in electronics:

  • Rework without RCA → identical soldering or placement defects recur next build.
  • Concessions off‑spec → IPC‑A‑610 criteria not referenced; “use‑as‑is” decisions lack functional risk assessment.
  • Records missing → audits flag “ineffective corrective action” or “incomplete nonconforming output control.”
  • COPQ ballooning → scrap/rework/complaints consume 15, 40% of total production cost in immature systems.

Electronics Quality Managers see these risks translate into missed deliveries, warranty exposure, and customer escalations, especially with OEM CSRs and PPAP‑like documentation expectations.

What Does a Structured, Audit‑ready MRB Workflow Look Like?

Below is a closed‑loop MRB mapped to standards and best practices.

Detection & Quarantine

  • Trigger: NCR from incoming inspection, in‑process, final test, or supplier complaint.
  • Action: Identify, segregate, hold (physical/IT “quarantine”); tag with NCR ID. Required by ISO 9001 8.7; common practice in AS9100/IATF.

Cross‑functional MRB Review

  • Team: Quality, Manufacturing/Process, Design/EE, Supply Chain; when applicable, Regulatory.
  • Inputs: Defect description, IPC‑A‑610 class/criteria, functional risk, supplier lot/traceability, test/FT results.

Standards‑aligned Disposition

  • Options: Rework/repair (per IPC‑A‑610/J‑STD‑001 limits), use‑as‑is under concession, return to vendor, scrap (rendered unusable). All require documented approvals/authority.
  • Medical electronics: Any acceptance of nonconforming product must have justification and signatures (820.90).

RCA → CAPA Linkage

  • When trends repeat, MRB outputs must feed CAPA (ISO 9001 10.2; AS9100 10.2) with formal RCA (5 Whys/Fishbone/FMEA), effectiveness checks, and management review visibility.
  • Best practice: Integrate NCRs with CAPA so every MRB decision either closes with justification or escalates to systemic corrective action.

Analytics & COPQ

  • Dashboards: Pareto by failure mode, line, supplier, component footprint; trend repeat NCRs; track average days to closure and CAPA effectiveness.

MRB Maturity, What Auditors (And Customers) Will See

Capability Ad-hoc MRB (risk) Structured MRB (audit-ready)
Quarantine control Items linger in staging; unclear segregation. Physical/IT quarantine; hold tags with NCR IDs; access control.
Disposition authority Decisions by whoever is available; no signatures. Named MRB roles; sign-off captured; authority recorded per ISO 8.7.2/FDA 820.90.
Standards criteria “Use-as-is” without referencing IPC criteria. IPC-A-610 class criteria and rework limits embedded in MRB forms.
Scrap control Scrap piles; risk of unintended use. Scrap rendered unusable; positive control documented (IATF/AS9100).
Traceability Photos/spreadsheets scattered; weak linkage. NCR ↔ MRB ↔ CAPA closed loop; supplier lot and work order traceability.
Prevent recurrence Rework fixes symptoms; repeat NCRs. RCA + CAPA with effectiveness verification (ISO 10.2).

How ComplianceQuest (CQ) Operationalizes Structured MRB For Electronics

  • Digitized MRB workflow: Log every decision, capture justification, authority, and related artifacts (photos, test data). Aligns to ISO 9001 8.7.2 record‑keeping and FDA 820.90 documentation expectations.
  • IPC‑A‑610 criteria at your fingertips: Embed class criteria and rework limits in the MRB template to guard against informal concessions.
  • Closed‑loop traceability: Link MRB cases directly to NCRs and CAPAs with RCA tools and effectiveness checks, industry best practice for preventing recurrence.
  • Audit readiness by design: Role‑based approvals, digital signatures, and immutable audit trails satisfy ISO/AS/IATF documentation expectations.
  • Supplier escalation: Integrate with supplier NCRs; enforce CSRs and concession workflows; share MRB evidence with customers as needed.
  • Analytics on COPQ: Dashboards reveal repeat nonconformities, slow closures, and high‑impact failure modes; drive Pareto‑based improvement and budget‑level COPQ reduction.

“When MRB decisions are systematically linked to NCRs and CAPAs in one digital system, companies reduce repeat NCRs and close audits faster.”

Implementation playbook for an electronics VP of Quality (next 90 days)

  • Codify authority & criteria: Define MRB roles, signature authority, and IPC‑A‑610 references in the MRB SOP. Map ISO 8.7/10.2 clauses to specific fields in your MRB/NCR records.
  • Digitize quarantine & tags: Enforce hold tags with NCR IDs; ensure physical/IT segregation and “positive control” of scrap where applicable (IATF/AS9100).
  • Standardize dispositions & concessions: Require documented justification for use‑as‑is decisions; for medical electronics, capture FDA‑style signatures and notification steps.
  • Automate NCR→CAPA linkage: Trigger CAPA for repeat modes; embed RCA templates; verify effectiveness before closure.
  • Stand‑up visibility KPIs: Track Avg. days to MRB close, % repeat NCRs, % NCRs escalated to CAPA, COPQ trend; review monthly with operations.

Frequently Asked Questions

    • Because ISO 9001 separates operational containment (8.7) from systemic prevention (10.2). Rework without RCA/CAPA breeds repeat defects and is a common audit finding; MRB must be documented and linked to CAPA where trends exist.
    • Yes. IPC‑A‑610 defines acceptability/rework limits for electronics assemblies; embedding these criteria prevents unsafe concessions and maintains common language with customers.
    • AS9100 requires rigorous control, documented information, and positive control of scrap/concessions; IATF 16949 expects unusable scrap and strong segregation to prevent unintended use. Both raise the bar on MRB traceability.
    • For electronics in medical devices, FDA 820.90 requires documented procedures for nonconforming product, including justification for use and signature authority. MRB must satisfy these requirements.
    • Mature MRB + NCR/CAPA integration reduces repeat NCRs and audit cycle time, and targets COPQ drivers via Pareto. While results vary by mix/volume, the direction is consistent in published best practice.

Request a Free Demo

Learn about all features of our Product, Quality, Safety, and Supplier suites. Please fill the form below to access our comprehensive Demo Video.

Please confirm your details

Graphic
spinner
Consult Now

Comments